In 1972, Henry Gadsden, then the chairman of the pharmaceutical giant Merck, sat for an interview with Fortune magazine and issued a statement that would haunt the company’s strategic legacy for decades. Gadsden remarked that he wanted Merck to be more like Wrigley’s chewing gum, expressing a desire to sell medicine to people who were perfectly healthy. His logic was mathematically sound but strategically hollow: the market for the sick is finite, while the market for the healthy is universal. By attempting to pivot a research-heavy institution toward the mass-market appeal of a consumer packaged good, Gadsden inadvertently signaled the beginning of an era where "relatability" and "reach" began to supersede clinical specificity. The result was not a golden age of expansion, but a period of regulatory friction and a dilution of the very expertise that had made Merck a cornerstone of the Dow Jones Industrial Average.

The Gadsden error remains the most persistent trap in modern commerce. It is the belief that by lowering the barrier of entry—whether through language, price, or brand persona—a business can capture a larger share of the human experience. In the current digital economy, this manifests as the "relatability mandate." Founders are told to be vulnerable, consultants are told to use "plain English," and corporations spend millions on social media teams tasked with making a multi-billion dollar entity sound like a quirky twenty-something. This drive for accessibility ignores a fundamental law of economic exchange: value is derived from the gap between what the provider knows and what the customer does not. When you bridge that gap with forced relatability, you often bridge the very reason for your premium.